These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 38990351)

  • 1. Correlation between serum cardiac troponin I level and PDAI score in patients with pemphigus vulgaris.
    Aryanian Z; Shakoei S; Esmaeili N; Daneshpazhooh M; Khayyat A; Bazrafshan F; Hatami P
    Arch Dermatol Res; 2024 Jul; 316(7):466. PubMed ID: 38990351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Ear, Nose, and Throat Involvement in Pemphigus Vulgaris in Comparison with Pemphigus Severity Scoring Systems: A Cross-sectional Study.
    Bilgic-Teme A; Cem Temel I; Bostancı-Toptas A; Turhan M; Bozkurt S; Uzun S
    Acta Dermatovenerol Croat; 2018 Dec; 26(4):283-288. PubMed ID: 30665476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does interleukin-33 level correlate with the activity of Pemphigus vulgaris?: A case-control study.
    Bakr RM; Sayed DS; Abd-Elkader AS; Kamel AA; Badran AY
    Dermatol Ther; 2021 Jan; 34(1):e14605. PubMed ID: 33249704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pemphigus disease activity measurements: pemphigus disease area index, autoimmune bullous skin disorder intensity score, and pemphigus vulgaris activity score.
    Rahbar Z; Daneshpazhooh M; Mirshams-Shahshahani M; Esmaili N; Heidari K; Aghazadeh N; Hejazi P; Ghajarzadeh M; Chams-Davatchi C
    JAMA Dermatol; 2014 Mar; 150(3):266-72. PubMed ID: 24429657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of anti-desmoglein antibodies levels and other laboratory indexes as objective comprehensive indicators of patients with pemphigus vulgaris of different severity: a single-center retrospective study.
    Lin X; Li X
    Clin Exp Med; 2023 Jun; 23(2):511-518. PubMed ID: 35445951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Oral Disease Severity Score validated for use in oral pemphigus vulgaris.
    Ormond M; McParland H; Donaldson ANA; Andiappan M; Cook RJ; Escudier M; Hullah E; Higham J; McMillan R; Taylor J; Shirlaw PJ; Challacombe SJ; Setterfield JF
    Br J Dermatol; 2018 Oct; 179(4):872-881. PubMed ID: 29297927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of serum cytokines and chemokines levels and clinical significance in patients with pemphigus vulgaris-A retrospective study.
    You S; Ouyang J; Wu Q; Zhang Y; Gao J; Luo X; Wang Y; Wu Y; Jiang F
    Exp Dermatol; 2024 Sep; 33(9):e15173. PubMed ID: 39246287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum levels of soluble PD1 in pemphigus vulgaris: A useful marker for disease severity.
    Zeid OA; Rashed L; Khalifa S; Saleh MA; Ragab N
    J Cosmet Dermatol; 2021 Apr; 20(4):1298-1302. PubMed ID: 32920962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing the Correlation Between Disease Severity Indices and Quality of Life Measurement Tools in Pemphigus.
    Krain RL; Kushner CJ; Tarazi M; Gaffney RG; Yeguez AC; Zamalin DE; Pearson DR; Feng R; Payne AS; Werth VP
    Front Immunol; 2019; 10():2571. PubMed ID: 31781098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The elevated level of osteopontin in patients with pemphigus vulgaris: A cytokine-like protein with a therapeutic potential.
    Ketabi Y; Nasiri S; Kheirodin M; Tavakolpour S; Mozafari N
    Dermatol Ther; 2019 Jul; 32(4):e12973. PubMed ID: 31136685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ODSS vs. ABSIS and PDAI oral parts in pemphigus vulgaris: inter-rater reliability and testing times.
    Shamabadi A; Yazdinezhad S; Sadeghi Y; Moradi AR; Yazdchi A; Teymourpour A; Faramarzi A; Seirafi R; Balighi K; Mahmoudi H; Daneshpazhooh M
    Oral Dis; 2023 Oct; 29(7):2696-2704. PubMed ID: 35852132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Large International Validation of ABSIS and PDAI Pemphigus Severity Scores.
    Hébert V; Boulard C; Houivet E; Duvert Lehembre S; Borradori L; Della Torre R; Feliciani C; Fania L; Zambruno G; Camaioni DB; Didona B; Marinovic B; Schmidt E; Schumacher N; Hünefeld C; Schanz S; Kern JS; Hofmann S; Bouyeure AC; Picard-Dahan C; Prost-Squarcioni C; Caux F; Alexandre M; Ingen-Housz-Oro S; Bagot M; Tancrede-Bohin E; Bouaziz JD; Franck N; Vabres P; Labeille B; Richard MA; Delaporte E; Dupuy A; D'Incan M; Quereux G; Skowro F; Paul C; Livideanu CB; Beylot-Barry M; Doutre MS; Avenel-Audran M; Bedane C; Bernard P; Machet L; Maillard H; Jullien D; Debarbieux S; Sassolas B; Misery L; Abasq C; Dereure O; Lagoutte P; Ferranti V; Werth VP; Murrell DF; Hertl M; Benichou J; Joly P; ;
    J Invest Dermatol; 2019 Jan; 139(1):31-37. PubMed ID: 30301637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation Value and Clinical Significance of Cardiac Troponin Level and Pediatric Sequential Organ Failure Score in the Definition of Sepsis 3.0 in Critically Ill Children.
    Wu Y; Shen W; Wang Q; Cui C; Zha L; Lu YJ; Liu R; Lin X; Zhu H
    Comput Math Methods Med; 2022; 2022():9492178. PubMed ID: 35983521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calculation of cut-off values based on the Autoimmune Bullous Skin Disorder Intensity Score (ABSIS) and Pemphigus Disease Area Index (PDAI) pemphigus scoring systems for defining moderate, significant and extensive types of pemphigus.
    Boulard C; Duvert Lehembre S; Picard-Dahan C; Kern JS; Zambruno G; Feliciani C; Marinovic B; Vabres P; Borradori L; Prost-Squarcioni C; Labeille B; Richard MA; Ingen-Housz-Oro S; Houivet E; Werth VP; Murrell DF; Hertl M; Benichou J; Joly P;
    Br J Dermatol; 2016 Jul; 175(1):142-9. PubMed ID: 26800395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Myocardial Injury Using Serum Cardiac Troponin-I in Asphyxiated Neonates at Enugu State University Teaching Hospital, Enugu, South-East Nigeria.
    Nwankwo O; Adiele DK; Ekwochi U; Idoko CA; Obidike EK
    Niger J Clin Pract; 2024 Jun; 27(6):792-799. PubMed ID: 38943306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salivary and Serum Anti-Desmoglein 1 and 3 ELISA and Indirect Immunofluorescence in Pemphigus Vulgaris: Correlations with Serum ELISA, Indirect Immunofluorescence and Disease Severity.
    Koopai M; Mortazavi H; Khatami A; Khodashenas Z
    Acta Dermatovenerol Croat; 2018 Jun; 26(2):91-99. PubMed ID: 29989863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mean Platelet Volume in Pemphigus Vulgaris.
    Kridin K; Shihade W; Zelber-Sagi S
    Angiology; 2018 Apr; 69(4):303-307. PubMed ID: 28681645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum cardiac troponin I is related to increased left ventricular wall thickness, left ventricular dysfunction, and male gender in hypertrophic cardiomyopathy.
    Kubo T; Kitaoka H; Okawa M; Yamanaka S; Hirota T; Hoshikawa E; Hayato K; Yamasaki N; Matsumura Y; Yasuda N; Sugiura T; Doi YL
    Clin Cardiol; 2010 Feb; 33(2):E1-7. PubMed ID: 20043329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum levels of cardiac troponin I in patients with status epilepticus and healthy cardiovascular system.
    Mehrpour M; Hajsadeghi S; Fereshtehnejad SM; Mehrpour M; Bassir P
    Arch Med Res; 2013 Aug; 44(6):449-53. PubMed ID: 24036082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac Troponin I: A Valuable Biomarker Indicating the Cardiac Involvement in Fabry Disease.
    Tanislav C; Guenduez D; Liebetrau C; Giese AK; Eichler S; Sieweke N; Speth M; Bauer T; Hamm C; Rolfs A
    PLoS One; 2016; 11(6):e0157640. PubMed ID: 27322070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.